All posts by Scott Power
Senior Analyst
Sectors Covered: Healthcare, Life Sciences
By Scott Power
26 May 2022, 9:30 AM
Nanosonics (ASX:NAN) provided a solid trading update with 3Q sales and installed base growing in line with 2Q, the company noted it anticipates FY22 revenue will be in line with consensus.
Read more...
By Scott Power
21 October 2021, 8:00 AM
We have realigned our cost base in line with management guidance. This has resulted in a downgraded to our short-term forecasts.
Read more...
By Scott Power
03 September 2021, 9:00 AM
Ebos Group (ASX:EBO) has added to its medical consumables portfolio, with the well flagged acquisition of a medical consumables business.
Read more...
By Scott Power
24 August 2021, 7:00 AM
Mach7 Technologies (ASX:M7T) posted an in-line result for FY21. The highlights included a record sales order book and further R&D spend (28% of revenue) into new product development.
Read more...
By Scott Power
19 August 2021, 12:00 PM
Ebos Group (ASX:EBO) posted a strong FY21 result in line with our forecasts, with the highest recorded ROCE (18.0%) reflected by double digit earnings growth.
Read more...
By Scott Power
18 August 2021, 1:00 PM
Ebos Group (ASX:EBO) posted a strong FY21 result in line with our forecasts, with the highest recorded ROCE (18.0%) reflected by double digit earnings growth.
Read more...
By Scott Power
10 August 2021, 9:30 AM
The Morgans Healthcare Team provides a preview of the upcoming reporting season, highlighting their key stock picks.
Read more...
By Scott Power
09 July 2021, 5:00 PM
Senior Analyst Scott Power, updates on stocks in the Healthcare sector.
Read more...
By Scott Power
01 July 2021, 4:00 PM
Nanosonics (ASX:NAN) has launched a new digital platform, AuditPro™ offering digital traceability, reporting and compliance providing a new revenue stream which we think has good potential.
Read more...
By Scott Power
15 April 2021, 8:00 AM
Morgans Senior Analyst Scott Power speaks with Chief Executive Officer of Control Bionics, Rob Wong, on the significant progress the healthcare company is making.
Read more...